SciSparc Ltd. (SPRC)
1.50
+0.41
(+37.61%)
USD |
NASDAQ |
Oct 26, 11:01
SciSparc Enterprise Value : 0.1773M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.1773M |
| October 22, 2026 | 0.2412M |
| October 21, 2026 | 0.3225M |
| October 20, 2026 | 0.3167M |
| October 19, 2026 | 0.3574M |
| October 16, 2026 | 0.5317M |
| October 15, 2026 | 0.706M |
| October 14, 2026 | 1.653M |
| October 13, 2026 | 1.833M |
| October 12, 2026 | 1.914M |
| October 09, 2026 | 2.141M |
| October 08, 2026 | 2.118M |
| October 07, 2026 | 2.240M |
| October 06, 2026 | 2.060M |
| October 05, 2026 | 2.077M |
| October 02, 2026 | 2.286M |
| October 01, 2026 | 2.188M |
| September 30, 2026 | 2.286M |
| September 29, 2026 | 2.278M |
| September 28, 2026 | 2.397M |
| September 25, 2026 | 2.571M |
| September 24, 2026 | 2.676M |
| September 23, 2026 | 2.455M |
| September 22, 2026 | 2.199M |
| September 21, 2026 | 2.176M |
| Date | Value |
|---|---|
| September 18, 2026 | 2.164M |
| September 17, 2026 | 2.129M |
| September 16, 2026 | 2.263M |
| September 15, 2026 | 2.310M |
| September 14, 2026 | 2.397M |
| September 11, 2026 | 2.496M |
| September 10, 2026 | 2.420M |
| September 09, 2026 | 2.420M |
| September 08, 2026 | 2.507M |
| September 04, 2026 | 2.618M |
| September 03, 2026 | 2.524M |
| September 02, 2026 | 2.943M |
| September 01, 2026 | 2.838M |
| August 31, 2026 | 3.396M |
| August 28, 2026 | 3.367M |
| August 27, 2026 | 3.390M |
| August 26, 2026 | 3.460M |
| August 25, 2026 | 3.431M |
| August 24, 2026 | 3.414M |
| August 21, 2026 | 3.434M |
| August 20, 2026 | 3.393M |
| August 19, 2026 | 3.530M |
| August 18, 2026 | 3.326M |
| August 17, 2026 | 3.402M |
| August 14, 2026 | 3.373M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 59.14B |
| RedHill Biopharma Ltd. | -11.30M |
| MediWound Ltd. | 129.12M |
| Purple Biotech Ltd. | -4.281M |
| Sol-Gel Technologies Ltd. | 180.22M |
Enterprise Value Related Metrics
| Earnings Yield | -5.30K% |
| Normalized Earnings Yield | -5165.03 |